EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Comparative Biochemistry and Physiology, Part C: Toxicology & Pharmacology


 

Status
active
Predecessor
Comparative Biochemistry and Physiology Part C: Comparative Pharmacology;
Subject

Source type
Journal
Publisher
ISBN ISSN
0742-8413
First volume
106
Last volume
127
Publish city
New York
Homepage

Source type
Journal
Publisher
ISBN ISSN
1532-0456
First volume
128
Last volume
148+
Homepage
Description

The Journal receives editorial direction from all the major societies in the field (European Society for Comparative Physiology and Biochemistry, the Japanese Society for Comparative Physiology and Biochemistry, Canadian Society of Zoologists (CBP Section), the Society for Experimental Biology, the Society for Integrative and Comparative Biology (formerly the American Society for Zoologists), the Australian and New Zealand Society for Comparative Physiology and Biochemistry, the South American Society for Comparative Physiology & Biochemistry, the Russian Physiological Society, and the Chinese Association for Physiological Sciences).

Part C: Toxicology and Pharmacology is concerned with chemical and drug action at different levels of organization, biotransformation of xenobiotics, mechanisms of toxicity, including reactive oxygen species and carcinogenesis, endocrine disruptors, natural products chemistry, and signal transduction with a molecular approach to these fields. 

 



Related links:









Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )